Sujan Shresta

Title(s)Adjunct Professor, Pediatrics
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A new mRNA antigen vaccine induces potent B and T cell responses and in vivo protection against SARS-CoV-2. NPJ Vaccines. 2026 Mar 24; 11(1). Wen J, Moon J, Tucciarone L, Bu TH, Sun AY, Miller R, Timis J, Wu L, Smith DM, Shresta S, Gaulton KJ, Rana TM. PMID: 41876554; PMCID: PMC13172340.
      View in: PubMed   Mentions:
    2. A new mRNA antigen vaccine induces potent B and T cell responses and in vivo protection against SARS-CoV-2. bioRxiv. 2026 Mar 03. Wen J, Moon J, Tucciarone L, Bu TH, Sun AY, Miller R, Timis J, Wu L, Smith DM, Shresta S, Gaulton KJ, Rana TM. PMID: 41847012; PMCID: PMC12991076.
      View in: PubMed   Mentions:
    3. Structure of a SARS-CoV-2 spike S2 subunit in a pre-fusion, open conformation. Cell Rep. 2025 Aug 26; 44(8):116052. Olmedillas E, Rajamanickam RR, Avalos RD, Ana-Sosa-Batiz F, Zyla D, Zandonatti MA, Harkins SS, Shresta S, Hastie KM, Saphire EO. PMID: 40705599.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    4. Structural stabilization of the intrinsically disordered SARS-CoV-2 N by binding to RNA sequences engineered from the viral genome fragment. Nat Commun. 2025 Jul 15; 16(1):6521. Landeras-Bueno S, Hariharan C, Avalos RD, Norris AS, Snyder DT, Hastie KM, Harkins S, Zandonatti M, Rajamanickam RR, Olmedillas E, Miller R, Shresta S, Wysocki VH, Saphire EO. PMID: 40664703; PMCID: PMC12264264.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    5. Enhanced durability of a Zika virus self-amplifying RNA vaccine through combinatorial OX40 and 4-1BB agonism. JCI Insight. 2025 05 22; 10(10). Lu HH, Dos Santos Alves RP, Li QH, Eder L, Timis J, Madany H, Chuensirikulchai K, Varghese KV, Singh A, Le Tran L, Street A, Elong Ngono A, Croft M, Shresta S. PMID: 40178907; PMCID: PMC12128976.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    6. Zika but not Dengue virus infection limits NF-κB activity in human monocyte-derived dendritic cells and suppresses their ability to activate T cells. Nat Commun. 2025 Mar 25; 16(1):2695. Wang YT, Branche E, Xie J, McMillan RE, Ana-Sosa-Batiz F, Lu HH, Li QH, Clark AE, Valls Cuevas JM, Viramontes KM, Garretson AF, Dos Santos Alves RP, Heinz S, Benner C, Carlin AF, Shresta S. PMID: 40133263; PMCID: PMC11937581.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansCells
    7. A humanised ACE2, TMPRSS2, and FCGRT mouse model reveals the protective efficacy of anti-receptor binding domain antibodies elicited by SARS-CoV-2 hybrid immunity. EBioMedicine. 2025 Mar; 113:105619. Ana-Sosa-Batiz F, Verma SK, Shafee N, Miller R, Conner C, Hastie KM, Timis J, Maule E, Nguyen MN, Tran L, Varghese K, Madany H, Street AE, Zandonatti M, Moi ML, Jarnagin K, Webb DR, Saphire EO, Kim K, Shresta S. PMID: 40020261; PMCID: PMC11910679.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansAnimalsCells
    8. Co-immunization with spike and nucleocapsid based DNA vaccines for long-term protective immunity against SARS-CoV-2 Omicron. NPJ Vaccines. 2024 Dec 19; 9(1):252. Pinto PBA, Timis J, Chuensirikulchai K, Li QH, Lu HH, Maule E, Nguyen M, Alves RPDS, Verma SK, Ana-Sosa-Batiz F, Valentine K, Landeras-Bueno S, Kim K, Hastie K, Saphire EO, Alves A, Elong Ngono A, Shresta S. PMID: 39702529; PMCID: PMC11659323.
      View in: PubMed   Mentions: 4  
    9. Genomic sequencing and neutralizing serological profiles during acute dengue infection: A 2017 cohort study in Nepal. PLOS Glob Public Health. 2024; 4(11):e0002966. Prajapati S, Elong Ngono A, Mc Cauley M, Timis J, Shrestha S, Bastola A, Mandal SK, Ray Yadav S, Napit R, Moi ML, Yamabhai M, M Sessions O, Shresta S, Manandhar KD. PMID: 39535994; PMCID: PMC11560038.
      View in: PubMed   Mentions:
    10. Genomic surveillance of SARS-CoV-2 in Nepal. Microbiol Resour Announc. 2024 Dec 12; 13(12):e0078924. Khadka B, Napit R, Mihindukulasuriya KA, Shrestha S, Rauniyar R, Tuladhar ET, Droit L, Paredes AM, Jha R, Raut R, Jha BK, Handley SA, Elong-Ngono A, Shresta S, Wang D, Manandhar KD. PMID: 39530702; PMCID: PMC11636318.
      View in: PubMed   Mentions:
    11. Dengue virus surveillance in Nepal yields the first on-site whole genome sequences of isolates from the 2022 outbreak. BMC Genomics. 2024 Oct 24; 25(1):998. Napit R, Elong Ngono A, Mihindukulasuriya KA, Pradhan A, Khadka B, Shrestha S, Droit L, Paredes A, Karki L, Khatiwada R, Tamang M, Chalise BS, Rawal M, Jha BK, Wang D, Handley SA, Shresta S, Manandhar KD. PMID: 39449117; PMCID: PMC11515306.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCellsPHPublic Health
    12. Human immunodeficiency virus-1 genome from patient with fever, Nepal. Microbiol Resour Announc. 2024 Nov 12; 13(11):e0076824. Tuladhar ET, Chalise BS, Khadka B, Tamang M, Neupane J, Poudel S, Droit L, Mihindukulasuriya KA, Elong Ngono A, Basaula YN, Shresta S, Wang D, Manandhar KD. PMID: 39431871; PMCID: PMC11556044.
      View in: PubMed   Mentions:
    13. Influence of Th1 versus Th2 immune bias on viral, pathological, and immunological dynamics in SARS-CoV-2 variant-infected human ACE2 knock-in mice. EBioMedicine. 2024 Oct; 108:105361. Verma SK, Ana-Sosa-Batiz F, Timis J, Shafee N, Maule E, Pinto PBA, Conner C, Valentine KM, Cowley DO, Miller R, Elong Ngono A, Tran L, Varghese K, Dos Santos Alves RP, Hastie KM, Saphire EO, Webb DR, Jarnagin K, Kim K, Shresta S. PMID: 39353281; PMCID: PMC11472634.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    14. Gemykibivirus detection in acute encephalitis patients from Nepal. mSphere. 2024 07 30; 9(7):e0021924. Tuladhar ET, Shrestha S, Vernon S, Droit L, Mihindukulasuriya KA, Tamang M, Karki L, Elong Ngono A, Jha B, Awal BK, Chalise BS, Jha R, Shresta S, Wang D, Manandhar KD. PMID: 38904383; PMCID: PMC11287993.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansCells
    15. Genomic sequencing and neutralizing serological profiles during acute dengue infection: A 2017 cohort study in Nepal. bioRxiv. 2024 Jun 05. Prajapati S, Ngono AE, Cauley MM, Timis J, Shrestha S, Bastola A, Mandal SK, Yadav SR, Napit R, Moi ML, Yamabhai M, Sessions OM, Shresta S, Manandhar KD. PMID: 38895290; PMCID: PMC11185687.
      View in: PubMed   Mentions:
    16. Dengue Virus Surveillance in Nepal Yields the First On-Site Whole Genome Sequences of Isolates from the 2022 Outbreak. bioRxiv. 2024 Jun 03. Napit R, Ngono AE, Mihindukulasuriya KA, Pradhan A, Khadka B, Shrestha S, Droit L, Paredes A, Karki L, Khatiwada R, Tamang M, Chalise BS, Rawal M, Jha B, Wang D, Handley SA, Shresta S, Manandhar KD. PMID: 38895410; PMCID: PMC11185532.
      View in: PubMed   Mentions:
    17. Gemykibivirus detection in acute encephalitis patients from Nepal. medRxiv. 2024 Feb 15. Tuladhar ET, Shrestha S, Vernon S, Droit L, Mihindukulasuriya KA, Tamang M, Karki L, Ngono AE, Jha B, Awal BK, Chalise BS, Jha R, Shresta S, Wang D, Manandhar KD. PMID: 38405898; PMCID: PMC10889008.
      View in: PubMed   Mentions:
    18. Human coronavirus OC43-elicited CD4+ T cells protect against SARS-CoV-2 in HLA transgenic mice. Nat Commun. 2024 01 26; 15(1):787. Dos Santos Alves RP, Timis J, Miller R, Valentine K, Pinto PBA, Gonzalez A, Regla-Nava JA, Maule E, Nguyen MN, Shafee N, Landeras-Bueno S, Olmedillas E, Laffey B, Dobaczewska K, Mikulski Z, McArdle S, Leist SR, Kim K, Baric RS, Ollmann Saphire E, Elong Ngono A, Shresta S. PMID: 38278784; PMCID: PMC10817949.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansAnimalsCells
    19. Structure of a SARS-CoV-2 spike S2 subunit in a pre-fusion, open conformation. bioRxiv. 2023 Dec 15. Olmedillas E, Rajamanickam RR, Avalos RD, Sosa FA, Zandonatti MA, Harkins SS, Shresta S, Hastie KM, Saphire EO. PMID: 38168261; PMCID: PMC10760097.
      View in: PubMed   Mentions:
    20. Potent Omicron-neutralizing antibodies isolated from a patient vaccinated 6 months before Omicron emergence. Cell Rep. 2023 05 30; 42(5):112421. Hastie KM, Yu X, Ana-Sosa-Batiz F, Zyla DS, Harkins SS, Hariharan C, Wasserman H, Zandonatti MA, Miller R, Maule E, Kim K, Valentine KM, Shresta S, Saphire EO. PMID: 37083327; PMCID: PMC10083196.
      View in: PubMed   Mentions: 5     Fields:    Translation:AnimalsCells
    21. SARS-CoV-2 Omicron (B.1.1.529) shows minimal neurotropism in a double-humanized mouse model. Antiviral Res. 2023 04; 212:105580. Alves RPDS, Wang YT, Mikulski Z, McArdle S, Shafee N, Valentine KM, Miller R, Verma SK, Batiz FAS, Maule E, Nguyen MN, Timis J, Mann C, Zandonatti M, Alarcon S, Rowe J, Kronenberg M, Weiskopf D, Sette A, Hastie K, Saphire EO, Festin S, Kim K, Shresta S. PMID: 36940916; PMCID: PMC10027296.
      View in: PubMed   Mentions: 4     Fields:    Translation:HumansAnimalsCells
    22. Mouse models of Zika virus transplacental transmission. Antiviral Res. 2023 Feb; 210:105500. Li QH, Kim K, Shresta S. PMID: 36567026; PMCID: PMC9852097.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    23. SREBP2-dependent lipid gene transcription enhances the infection of human dendritic cells by Zika virus. Nat Commun. 2022 09 12; 13(1):5341. Branche E, Wang YT, Viramontes KM, Valls Cuevas JM, Xie J, Ana-Sosa-Batiz F, Shafee N, Duttke SH, McMillan RE, Clark AE, Nguyen MN, Garretson AF, Crames JJ, Spann NJ, Zhu Z, Rich JN, Spector DH, Benner C, Shresta S, Carlin AF. PMID: 36097162; PMCID: PMC9465152.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansCells
    24. Acute-phase Serum Cytokine Levels and Correlation with Clinical Outcomes in Children and Adults with Primary and Secondary Dengue Virus Infection in Myanmar between 2017 and 2019. Pathogens. 2022 May 09; 11(5). Nwe KM, Ngwe Tun MM, Myat TW, Sheng Ng CF, Htun MM, Lin H, Hom NS, Soe AM, Elong Ngono A, Hamano S, Morita K, Thant KZ, Shresta S, Thu HM, Moi ML. PMID: 35631079; PMCID: PMC9144711.
      View in: PubMed   Mentions: 3     Fields:    
    25. A Zika virus mutation enhances transmission potential and confers escape from protective dengue virus immunity. Cell Rep. 2022 04 12; 39(2):110655. Regla-Nava JA, Wang YT, Fontes-Garfias CR, Liu Y, Syed T, Susantono M, Gonzalez A, Viramontes KM, Verma SK, Kim K, Landeras-Bueno S, Huang CT, Prigozhin DM, Gleeson JG, Terskikh AV, Shi PY, Shresta S. PMID: 35417697; PMCID: PMC9093040.
      View in: PubMed   Mentions: 28     Fields:    Translation:AnimalsCells
    26. SARS-CoV-2 monoclonal antibodies with therapeutic potential: Broad neutralizing activity and No evidence of antibody-dependent enhancement. Antiviral Res. 2021 11; 195:105185. Wang YT, Allen RD, Kim K, Shafee N, Gonzalez AJ, Nguyen MN, Valentine KM, Cao X, Lu L, Pai CI, Johnson S, Kerwin L, Zhou H, Zhang Y, Shresta S. PMID: 34634289; PMCID: PMC8498781.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    27. The Ability of Zika virus Intravenous Immunoglobulin to Protect From or Enhance Zika Virus Disease. Front Immunol. 2021; 12:717425. Pinto AK, Hassert M, Han X, Barker D, Carnelley T, Branche E, Steffen TL, Stone ET, Geerling E, Viramontes KM, Nykiforuk C, Toth D, Shresta S, Kodihalli S, Brien JD. PMID: 34552587; PMCID: PMC8450494.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    28. Emergence of a Novel Dengue Virus 3 (DENV-3) Genotype-I Coincident with Increased DENV-3 Cases in Yangon, Myanmar between 2017 and 2019. Viruses. 2021 06 16; 13(6). Soe AM, Ngwe Tun MM, Nabeshima T, Myat TW, Htun MM, Lin H, Hom NS, Inoue S, Nwe KM, Aye LPP, Fukuta M, Thant KZ, Hasebe F, Morita K, Shresta S, Thu HM, Moi ML. PMID: 34208667; PMCID: PMC8235066.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansCellsPHPublic Health
    29. Repeated exposure to dengue virus elicits robust cross neutralizing antibodies against Zika virus in residents of Northeastern Thailand. Sci Rep. 2021 05 05; 11(1):9634. Hattakam S, Elong Ngono A, McCauley M, Shresta S, Yamabhai M. PMID: 33953258; PMCID: PMC8100282.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansCells
    30. Animal models for SARS-Cov2/Covid19 research-A commentary. Biochem Pharmacol. 2021 06; 188:114543. Jarnagin K, Alvarez O, Shresta S, Webb DR. PMID: 33812856; PMCID: PMC8016548.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    31. Human FcRn expression and Type I Interferon signaling control Echovirus 11 pathogenesis in mice. PLoS Pathog. 2021 01; 17(1):e1009252. Wells AI, Grimes KA, Kim K, Branche E, Bakkenist CJ, DePas WH, Shresta S, Coyne CB. PMID: 33513208; PMCID: PMC7875378.
      View in: PubMed   Mentions: 16     Fields:    Translation:HumansAnimalsCells
    32. Zika virus oncolytic activity requires CD8+ T cells and is boosted by immune checkpoint blockade. JCI Insight. 2021 01 11; 6(1). Nair S, Mazzoccoli L, Jash A, Govero J, Bais SS, Hu T, Fontes-Garfias CR, Shan C, Okada H, Shresta S, Rich JN, Shi PY, Diamond MS, Chheda MG. PMID: 33232299; PMCID: PMC7821591.
      View in: PubMed   Mentions: 55     Fields:    Translation:HumansAnimalsCells
    33. Whole Genome Sequencing of Dengue Virus Serotype 2 from Two Clinical Isolates and Serological Profile of Dengue in the 2015-2016 Nepal Outbreak. Am J Trop Med Hyg. 2021 01; 104(1):115-120. Manandhar KD, McCauley M, Gupta BP, Kurmi R, Adhikari A, Nguyen AV, Elong Ngono A, Zompi S, Sessions OM, Shresta S. PMID: 33073748; PMCID: PMC7790085.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsPHPublic Health
    34. CD8+ T cells mediate protection against Zika virus induced by an NS3-based vaccine. Sci Adv. 2020 11; 6(45). Elong Ngono A, Syed T, Nguyen AV, Regla-Nava JA, Susantono M, Spasova D, Aguilar A, West M, Sparks J, Gonzalez A, Branche E, DeHart JL, Vega JB, Karmali PP, Chivukula P, Kamrud K, Aliahmad P, Wang N, Shresta S. PMID: 33148638; PMCID: PMC7673678.
      View in: PubMed   Mentions: 27     Fields:    Translation:HumansAnimalsCells
    35. Japanese encephalitis virus-primed CD8+ T cells prevent antibody-dependent enhancement of Zika virus pathogenesis. J Exp Med. 2020 09 07; 217(9). Chen D, Duan Z, Zhou W, Zou W, Jin S, Li D, Chen X, Zhou Y, Yang L, Zhang Y, Shresta S, Wen J. PMID: 32501510; PMCID: PMC7478723.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    36. Protection against dengue virus requires a sustained balance of antibody and T cell responses. Curr Opin Virol. 2020 08; 43:22-27. Valentine KM, Croft M, Shresta S. PMID: 32798886; PMCID: PMC7655611.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    37. Spiking Pandemic Potential: Structural and Immunological Aspects of SARS-CoV-2. Trends Microbiol. 2020 08; 28(8):605-618. Wang YT, Landeras-Bueno S, Hsieh LE, Terada Y, Kim K, Ley K, Shresta S, Saphire EO, Regla-Nava JA. PMID: 32507543; PMCID: PMC7237910.
      View in: PubMed   Mentions: 22     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    38. CD4+ T Cells Cross-Reactive with Dengue and Zika Viruses Protect against Zika Virus Infection. Cell Rep. 2020 04 28; 31(4):107566. Wen J, Wang YT, Valentine KM, Dos Santos Alves RP, Xu Z, Regla-Nava JA, Ngono AE, Young MP, Ferreira LCS, Shresta S. PMID: 32348763; PMCID: PMC7261136.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansAnimalsCells
    39. Targeting Endoplasmic Reticulum α-Glucosidase I with a Single-Dose Iminosugar Treatment Protects against Lethal Influenza and Dengue Virus Infections. J Med Chem. 2020 04 23; 63(8):4205-4214. Warfield KL, Alonzi DS, Hill JC, Caputo AT, Roversi P, Kiappes JL, Sheets N, Duchars M, Dwek RA, Biggins J, Barnard D, Shresta S, Treston AM, Zitzmann N. PMID: 32227946.
      View in: PubMed   Mentions: 26     Fields:    Translation:HumansAnimalsCells
    40. Investigation of the immunogenicity of Zika glycan loop. Virol J. 2020 03 31; 17(1):43. Henderson EA, Tam CC, Cheng LW, Ngono AE, Nguyen AV, Shresta S, McGee M, Padgett H, Grill LK, Martchenko Shilman M. PMID: 32234060; PMCID: PMC7110905.
      View in: PubMed   Mentions: 6     Fields:    Translation:HumansAnimalsCells
    41. Human Polyclonal Antibodies Prevent Lethal Zika Virus Infection in Mice. Sci Rep. 2019 07 08; 9(1):9857. Branche E, Simon AY, Sheets N, Kim K, Barker D, Nguyen AT, Sahota H, Young MP, Salgado R, Mamidi A, Viramontes KM, Carnelley T, Qiu H, Elong Ngono A, Regla-Nava JA, Susantono MX, Valls Cuevas JM, Kennedy K, Kodihalli S, Shresta S. PMID: 31285451; PMCID: PMC6614477.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansAnimalsCells
    42. Cross-Reactive T Cell Immunity to Dengue and Zika Viruses: New Insights Into Vaccine Development. Front Immunol. 2019; 10:1316. Elong Ngono A, Shresta S. PMID: 31244855; PMCID: PMC6579874.
      View in: PubMed   Mentions: 43     Fields:    Translation:HumansAnimalsCells
    43. Correction: CD4+ T cells promote humoral immunity and viral control during Zika virus infection. PLoS Pathog. 2019 May; 15(5):e1007821. Elong Ngono A, Young MP, Bunz M, Xu Z, Hattakam S, Vizcarra E, Regla-Nava JA, Tang WW, Yamabhai M, Wen J, Shresta S. PMID: 31136625; PMCID: PMC6538173.
      View in: PubMed   Mentions: 1     Fields:    
    44. Antigenic cross-reactivity between Zika and dengue viruses: is it time to develop a universal vaccine? Curr Opin Immunol. 2019 08; 59:1-8. Wen J, Shresta S. PMID: 30884384; PMCID: PMC6745280.
      View in: PubMed   Mentions: 32     Fields:    Translation:HumansAnimalsCells
    45. Detection of Zika virus in mouse mammary gland and breast milk. PLoS Negl Trop Dis. 2019 02; 13(2):e0007080. Regla-Nava JA, Viramontes KM, Vozdolska T, Huynh AT, Villani T, Gardner G, Johnson M, Ferro PJ, Shresta S, Kim K. PMID: 30742628; PMCID: PMC6386411.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCells
    46. Zika Virus Protease Cleavage of Host Protein Septin-2 Mediates Mitotic Defects in Neural Progenitors. Neuron. 2019 03 20; 101(6):1089-1098.e4. Li H, Saucedo-Cuevas L, Yuan L, Ross D, Johansen A, Sands D, Stanley V, Guemez-Gamboa A, Gregor A, Evans T, Chen S, Tan L, Molina H, Sheets N, Shiryaev SA, Terskikh AV, Gladfelter AS, Shresta S, Xu Z, Gleeson JG. PMID: 30713029; PMCID: PMC6690588.
      View in: PubMed   Mentions: 44     Fields:    Translation:HumansCells
    47. CD4+ T cells promote humoral immunity and viral control during Zika virus infection. PLoS Pathog. 2019 01; 15(1):e1007474. Elong Ngono A, Young MP, Bunz M, Xu Z, Hattakam S, Vizcarra E, Regla-Nava JA, Tang WW, Yamabhai M, Wen J, Shresta S. PMID: 30677097; PMCID: PMC6345435.
      View in: PubMed   Mentions: 57     Fields:    Translation:AnimalsCellsPHPublic Health
    48. A longitudinal systems immunologic investigation of acute Zika virus infection in an individual infected while traveling to Caracas, Venezuela. PLoS Negl Trop Dis. 2018 12; 12(12):e0007053. Carlin AF, Wen J, Vizcarra EA, McCauley M, Chaillon A, Akrami K, Kim C, Ngono AE, Lara-Marquez ML, Smith DM, Glass CK, Schooley RT, Benner C, Shresta S. PMID: 30596671; PMCID: PMC6329527.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    49. Genome-wide approaches to unravelling host-virus interactions in Dengue and Zika infections. Curr Opin Virol. 2019 02; 34:29-38. Carlin AF, Shresta S. PMID: 30576956; PMCID: PMC6476700.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    50. Maternally Acquired Zika Antibodies Enhance Dengue Disease Severity in Mice. Cell Host Microbe. 2018 11 14; 24(5):743-750.e5. Fowler AM, Tang WW, Young MP, Mamidi A, Viramontes KM, McCauley MD, Carlin AF, Schooley RT, Swanstrom J, Baric RS, Govero J, Diamond MS, Shresta S. PMID: 30439343; PMCID: PMC6250068.
      View in: PubMed   Mentions: 60     Fields:    Translation:HumansAnimalsCells
    51. Deconvolution of pro- and antiviral genomic responses in Zika virus-infected and bystander macrophages. Proc Natl Acad Sci U S A. 2018 09 25; 115(39):E9172-E9181. Carlin AF, Vizcarra EA, Branche E, Viramontes KM, Suarez-Amaran L, Ley K, Heinz S, Benner C, Shresta S, Glass CK. PMID: 30206152; PMCID: PMC6166801.
      View in: PubMed   Mentions: 36     Fields:    Translation:HumansCells
    52. Cross-reactive Dengue virus-specific CD8+ T cells protect against Zika virus during pregnancy. Nat Commun. 2018 08 02; 9(1):3042. Regla-Nava JA, Elong Ngono A, Viramontes KM, Huynh AT, Wang YT, Nguyen AT, Salgado R, Mamidi A, Kim K, Diamond MS, Shresta S. PMID: 30072692; PMCID: PMC6072705.
      View in: PubMed   Mentions: 77     Fields:    Translation:AnimalsCells
    53. Synergism between the tyrosine kinase inhibitor sunitinib and Anti-TNF antibody protects against lethal dengue infection. Antiviral Res. 2018 10; 158:1-7. Branche E, Tang WW, Viramontes KM, Young MP, Sheets N, Joo Y, Nguyen AT, Shresta S. PMID: 30071205; PMCID: PMC6380672.
      View in: PubMed   Mentions: 14     Fields:    Translation:AnimalsCells
    54. Author Correction: Blocking Zika virus vertical transmission. Sci Rep. 2018 Jun 05; 8(1):8794. Mesci P, Macia A, Moore SM, Shiryaev SA, Pinto A, Huang CT, Tejwani L, Fernandes IR, Suarez NA, Kolar MJ, Montefusco S, Rosenberg SC, Herai RH, Cugola FR, Russo FB, Sheets N, Saghatelian A, Shresta S, Momper JD, Siqueira-Neto JL, Corbett KD, Beltrão-Braga PCB, Terskikh AV, Muotri AR. PMID: 29867187; PMCID: PMC5986756.
      View in: PubMed   Mentions: 3     Fields:    
    55. Blocking Zika virus vertical transmission. Sci Rep. 2018 01 19; 8(1):1218. Mesci P, Macia A, Moore SM, Shiryaev SA, Pinto A, Huang CT, Tejwani L, Fernandes IR, Suarez NA, Kolar MJ, Montefusco S, Rosenberg SC, Herai RH, Cugola FR, Russo FB, Sheets N, Saghatelian A, Shresta S, Momper JD, Siqueira-Neto JL, Corbett KD, Beltrão-Braga PCB, Terskikh AV, Muotri AR. PMID: 29352135; PMCID: PMC5775359.
      View in: PubMed   Mentions: 33     Fields:    
    56. Immune Response to Dengue and Zika. Annu Rev Immunol. 2018 04 26; 36:279-308. Ngono AE, Shresta S. PMID: 29345964; PMCID: PMC5910217.
      View in: PubMed   Mentions: 151     Fields:    Translation:HumansAnimalsCells
    57. Development of Zika Virus Vaccines. Vaccines (Basel). 2018 Jan 18; 6(1). Makhluf H, Shresta S. PMID: 29346287; PMCID: PMC5874648.
      View in: PubMed   Mentions: 14  
    58. Repurposing of the anti-malaria drug chloroquine for Zika Virus treatment and prophylaxis. Sci Rep. 2017 Nov 17; 7(1):15771. Shiryaev SA, Mesci P, Pinto A, Fernandes I, Sheets N, Shresta S, Farhy C, Huang CT, Strongin AY, Muotri AR, Terskikh AV. PMID: 29150641; PMCID: PMC5694003.
      View in: PubMed   Mentions: 67     Fields:    Translation:HumansAnimalsCells
    59. Dengue virus-reactive CD8+ T cells mediate cross-protection against subsequent Zika virus challenge. Nat Commun. 2017 11 13; 8(1):1459. Wen J, Elong Ngono A, Regla-Nava JA, Kim K, Gorman MJ, Diamond MS, Shresta S. PMID: 29129917; PMCID: PMC5682281.
      View in: PubMed   Mentions: 98     Fields:    Translation:AnimalsCells
    60. An IRF-3-, IRF-5-, and IRF-7-Independent Pathway of Dengue Viral Resistance Utilizes IRF-1 to Stimulate Type I and II Interferon Responses. Cell Rep. 2017 Nov 07; 21(6):1600-1612. Carlin AF, Plummer EM, Vizcarra EA, Sheets N, Joo Y, Tang W, Day J, Greenbaum J, Glass CK, Diamond MS, Shresta S. PMID: 29117564; PMCID: PMC5696617.
      View in: PubMed   Mentions: 46     Fields:    Translation:AnimalsCells
    61. T Cell Immunity to Zika and Dengue Viral Infections. J Interferon Cytokine Res. 2017 11; 37(11):475-479. Wen J, Shresta S. PMID: 29135369; PMCID: PMC5695673.
      View in: PubMed   Mentions: 17     Fields:    Translation:HumansAnimalsCells
    62. ADE-ing and Abetting Zika. Cell Host Microbe. 2017 May 10; 21(5):557-558. Wen J, Shresta S. PMID: 28494235; PMCID: PMC5808914.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansAnimalsCells
    63. Characterization of the Zika virus two-component NS2B-NS3 protease and structure-assisted identification of allosteric small-molecule antagonists. Antiviral Res. 2017 07; 143:218-229. Shiryaev SA, Farhy C, Pinto A, Huang CT, Simonetti N, Elong Ngono A, Dewing A, Shresta S, Pinkerton AB, Cieplak P, Strongin AY, Terskikh AV. PMID: 28461069; PMCID: PMC5558795.
      View in: PubMed   Mentions: 66     Fields:    Translation:HumansAnimalsCells
    64. Modified mRNA Vaccines Protect against Zika Virus Infection. Cell. 2017 03 23; 169(1):176. Richner JM, Himansu S, Dowd KA, Butler SL, Salazar V, Fox JM, Julander JG, Tang WW, Shresta S, Pierson TC, Ciaramella G, Diamond MS. PMID: 28340344.
      View in: PubMed   Mentions: 141     Fields:    
    65. Identification of Zika virus epitopes reveals immunodominant and protective roles for dengue virus cross-reactive CD8+ T cells. Nat Microbiol. 2017 Mar 13; 2:17036. Wen J, Tang WW, Sheets N, Ellison J, Sette A, Kim K, Shresta S. PMID: 28288094; PMCID: PMC5918137.
      View in: PubMed   Mentions: 113     Fields:    Translation:AnimalsCells
    66. Modified mRNA Vaccines Protect against Zika Virus Infection. Cell. 2017 03 09; 168(6):1114-1125.e10. Richner JM, Himansu S, Dowd KA, Butler SL, Salazar V, Fox JM, Julander JG, Tang WW, Shresta S, Pierson TC, Ciaramella G, Diamond MS. PMID: 28222903; PMCID: PMC5388441.
      View in: PubMed   Mentions: 438     Fields:    Translation:AnimalsCells
    67. Mapping and Role of the CD8+ T Cell Response During Primary Zika Virus Infection in Mice. Cell Host Microbe. 2017 Jan 11; 21(1):35-46. Elong Ngono A, Vizcarra EA, Tang WW, Sheets N, Joo Y, Kim K, Gorman MJ, Diamond MS, Shresta S. PMID: 28081442; PMCID: PMC5234855.
      View in: PubMed   Mentions: 175     Fields:    Translation:AnimalsCells
    68. A Mouse Model of Zika Virus Sexual Transmission and Vaginal Viral Replication. Cell Rep. 2016 12 20; 17(12):3091-3098. Tang WW, Young MP, Mamidi A, Regla-Nava JA, Kim K, Shresta S. PMID: 28009279; PMCID: PMC5193244.
      View in: PubMed   Mentions: 105     Fields:    Translation:HumansAnimalsCells
    69. The Neurobiology of Zika Virus. Neuron. 2016 Dec 07; 92(5):949-958. Li H, Saucedo-Cuevas L, Shresta S, Gleeson JG. PMID: 27930910.
      View in: PubMed   Mentions: 87     Fields:    Translation:HumansCells
    70. Protective Role of Cross-Reactive CD8 T Cells Against Dengue Virus Infection. EBioMedicine. 2016 Nov; 13:284-293. Elong Ngono A, Chen HW, Tang WW, Joo Y, King K, Weiskopf D, Sidney J, Sette A, Shresta S. PMID: 27746192; PMCID: PMC5264312.
      View in: PubMed   Mentions: 75     Fields:    Translation:AnimalsCells
    71. Zika Virus Infects Neural Progenitors in the Adult Mouse Brain and Alters Proliferation. Cell Stem Cell. 2016 11 03; 19(5):593-598. Li H, Saucedo-Cuevas L, Regla-Nava JA, Chai G, Sheets N, Tang W, Terskikh AV, Shresta S, Gleeson JG. PMID: 27545505; PMCID: PMC5097023.
      View in: PubMed   Mentions: 187     Fields:    Translation:AnimalsCells
    72. Novel strategies for discovering inhibitors of Dengue and Zika fever. Expert Opin Drug Discov. 2016 10; 11(10):921-3. Makhluf H, Kim K, Shresta S. PMID: 27401601.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    73. Neuroteratogenic Viruses and Lessons for Zika Virus Models. Trends Microbiol. 2016 08; 24(8):622-636. Kim K, Shresta S. PMID: 27387029.
      View in: PubMed   Mentions: 19     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    74. Inhibition of endoplasmic reticulum glucosidases is required for in vitro and in vivo dengue antiviral activity by the iminosugar UV-4. Antiviral Res. 2016 May; 129:93-98. Warfield KL, Plummer EM, Sayce AC, Alonzi DS, Tang W, Tyrrell BE, Hill ML, Caputo AT, Killingbeck SS, Beatty PR, Harris E, Iwaki R, Kinami K, Ide D, Kiappes JL, Kato A, Buck MD, King K, Eddy W, Khaliq M, Sampath A, Treston AM, Dwek RA, Enterlein SG, Miller JL, Zitzmann N, Ramstedt U, Shresta S. PMID: 26946111; PMCID: PMC5064435.
      View in: PubMed   Mentions: 38     Fields:    Translation:HumansAnimalsCells
    75. Defining New Therapeutics Using a More Immunocompetent Mouse Model of Antibody-Enhanced Dengue Virus Infection. mBio. 2015 Sep 15; 6(5):e01316-15. Pinto AK, Brien JD, Lam CY, Johnson S, Chiang C, Hiscott J, Sarathy VV, Barrett AD, Shresta S, Diamond MS. PMID: 26374123; PMCID: PMC4600115.
      View in: PubMed   Mentions: 31     Fields:    Translation:AnimalsCells
    76. Protection against dengue disease by synthetic nucleic acid antibody prophylaxis/immunotherapy. Sci Rep. 2015 Jul 29; 5:12616. Flingai S, Plummer EM, Patel A, Shresta S, Mendoza JM, Broderick KE, Sardesai NY, Muthumani K, Weiner DB. PMID: 26220099; PMCID: PMC4518257.
      View in: PubMed   Mentions: 53     Fields:    Translation:HumansAnimalsCells
    77. Different STAT Transcription Complexes Drive Early and Delayed Responses to Type I IFNs. J Immunol. 2015 Jul 01; 195(1):210-216. Abdul-Sater AA, Majoros A, Plumlee CR, Perry S, Gu AD, Lee C, Shresta S, Decker T, Schindler C. PMID: 26019270; PMCID: PMC4617678.
      View in: PubMed   Mentions: 23     Fields:    Translation:AnimalsCells
    78. Influence of antibodies and T cells on dengue disease outcome: insights from interferon receptor-deficient mouse models. Curr Opin Virol. 2015 Aug; 13:61-6. Tang WW, Grewal R, Shresta S. PMID: 26001278.
      View in: PubMed   Mentions: 9     Fields:    Translation:HumansAnimalsCells
    79. A Novel Iminosugar UV-12 with Activity against the Diverse Viruses Influenza and Dengue (Novel Iminosugar Antiviral for Influenza and Dengue). Viruses. 2015 May 13; 7(5):2404-27. Warfield KL, Plummer E, Alonzi DS, Wolfe GW, Sampath A, Nguyen T, Butters TD, Enterlein SG, Stavale EJ, Shresta S, Ramstedt U. PMID: 25984714; PMCID: PMC4452912.
      View in: PubMed   Mentions: 17     Fields:    Translation:AnimalsCells
    80. CD8+ T Cells Can Mediate Short-Term Protection against Heterotypic Dengue Virus Reinfection in Mice. J Virol. 2015 Jun; 89(12):6494-505. Zellweger RM, Tang WW, Eddy WE, King K, Sanchez MC, Shresta S. PMID: 25855749; PMCID: PMC4474296.
      View in: PubMed   Mentions: 61     Fields:    Translation:AnimalsCells
    81. Dengue Virus Evolution under a Host-Targeted Antiviral. J Virol. 2015 May; 89(10):5592-601. Plummer E, Buck MD, Sanchez M, Greenbaum JA, Turner J, Grewal R, Klose B, Sampath A, Warfield KL, Peters B, Ramstedt U, Shresta S. PMID: 25762732; PMCID: PMC4442503.
      View in: PubMed   Mentions: 33     Fields:    Translation:HumansAnimalsCells
    82. Innate Antiviral Immunity against Dengue Virus. Crit Rev Immunol. 2015; 35(3):253-60. Makhluf H, Shresta S. PMID: 26559229.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    83. CD8+ T cells prevent antigen-induced antibody-dependent enhancement of dengue disease in mice. J Immunol. 2014 Oct 15; 193(8):4117-24. Zellweger RM, Eddy WE, Tang WW, Miller R, Shresta S. PMID: 25217165; PMCID: PMC4185219.
      View in: PubMed   Mentions: 66     Fields:    Translation:AnimalsCells
    84. Immunodominance changes as a function of the infecting dengue virus serotype and primary versus secondary infection. J Virol. 2014 Oct; 88(19):11383-94. Weiskopf D, Angelo MA, Sidney J, Peters B, Shresta S, Sette A. PMID: 25056881; PMCID: PMC4178794.
      View in: PubMed   Mentions: 63     Fields:    Translation:HumansAnimalsCells
    85. Mouse models to study dengue virus immunology and pathogenesis. Front Immunol. 2014; 5:151. Zellweger RM, Shresta S. PMID: 24782859; PMCID: PMC3989707.
      View in: PubMed   Mentions: 69     Fields:    
    86. Mouse models for dengue vaccines and antivirals. J Immunol Methods. 2014 Aug; 410:34-8. Plummer EM, Shresta S. PMID: 24440090.
      View in: PubMed   Mentions: 12     Fields:    Translation:HumansAnimalsCells
    87. Animal models in dengue. Methods Mol Biol. 2014; 1138:377-90. Plummer E, Shresta S. PMID: 24696349.
      View in: PubMed   Mentions: 3     Fields:    Translation:AnimalsCells
    88. Dengue virus vaccine development. Adv Virus Res. 2014; 88:315-72. Yauch LE, Shresta S. PMID: 24373316.
      View in: PubMed   Mentions: 29     Fields:    Translation:HumansCells
    89. Role of humoral versus cellular responses induced by a protective dengue vaccine candidate. PLoS Pathog. 2013 Oct; 9(10):e1003723. Zellweger RM, Miller R, Eddy WE, White LJ, Johnston RE, Shresta S. PMID: 24204271; PMCID: PMC3814346.
      View in: PubMed   Mentions: 61     Fields:    Translation:HumansAnimalsCellsPHPublic Health
    90. The roles of IRF-3 and IRF-7 in innate antiviral immunity against dengue virus. J Immunol. 2013 Oct 15; 191(8):4194-201. Chen HW, King K, Tu J, Sanchez M, Luster AD, Shresta S. PMID: 24043884; PMCID: PMC3795795.
      View in: PubMed   Mentions: 50     Fields:    Translation:AnimalsCells
    91. Inhibitory and combinatorial effect of diphyllin, a v-ATPase blocker, on influenza viruses. Antiviral Res. 2013 Sep; 99(3):371-82. Chen HW, Cheng JX, Liu MT, King K, Peng JY, Zhang XQ, Wang CH, Shresta S, Schooley RT, Liu YT. PMID: 23820269; PMCID: PMC3787953.
      View in: PubMed   Mentions: 35     Fields:    Translation:HumansAnimalsCells
    92. Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells. Proc Natl Acad Sci U S A. 2013 May 28; 110(22):E2046-53. Weiskopf D, Angelo MA, de Azeredo EL, Sidney J, Greenbaum JA, Fernando AN, Broadwater A, Kolla RV, De Silva AD, de Silva AM, Mattia KA, Doranz BJ, Grey HM, Shresta S, Peters B, Sette A. PMID: 23580623; PMCID: PMC3670335.
      View in: PubMed   Mentions: 375     Fields:    Translation:HumansCells
    93. An iminosugar with potent inhibition of dengue virus infection in vivo. Antiviral Res. 2013 Apr; 98(1):35-43. Perry ST, Buck MD, Plummer EM, Penmasta RA, Batra H, Stavale EJ, Warfield KL, Dwek RA, Butters TD, Alonzi DS, Lada SM, King K, Klose B, Ramstedt U, Shresta S. PMID: 23376501.
      View in: PubMed   Mentions: 48     Fields:    Translation:HumansAnimalsCells
    94. Tracking the evolution of dengue virus strains D2S10 and D2S20 by 454 pyrosequencing. PLoS One. 2013; 8(1):e54220. Makhluf H, Buck MD, King K, Perry ST, Henn MR, Shresta S. PMID: 23342105; PMCID: PMC3544829.
      View in: PubMed   Mentions: 15     Fields:    Translation:AnimalsCells
    95. Gamma interferon (IFN-γ) receptor restricts systemic dengue virus replication and prevents paralysis in IFN-α/β receptor-deficient mice. J Virol. 2012 Dec; 86(23):12561-70. Prestwood TR, Morar MM, Zellweger RM, Miller R, May MM, Yauch LE, Lada SM, Shresta S. PMID: 22973027; PMCID: PMC3497655.
      View in: PubMed   Mentions: 77     Fields:    Translation:AnimalsCells
    96. Trafficking and replication patterns reveal splenic macrophages as major targets of dengue virus in mice. J Virol. 2012 Nov; 86(22):12138-47. Prestwood TR, May MM, Plummer EM, Morar MM, Yauch LE, Shresta S. PMID: 22933295; PMCID: PMC3486461.
      View in: PubMed   Mentions: 40     Fields:    Translation:AnimalsCells
    97. Role of complement in dengue virus infection: protection or pathogenesis? mBio. 2012; 3(1). Shresta S. PMID: 22318317; PMCID: PMC3280461.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    98. Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design. J Immunol. 2011 Oct 15; 187(8):4268-79. Weiskopf D, Yauch LE, Angelo MA, John DV, Greenbaum JA, Sidney J, Kolla RV, De Silva AD, de Silva AM, Grey H, Peters B, Shresta S, Sette A. PMID: 21918184; PMCID: PMC3186824.
      View in: PubMed   Mentions: 77     Fields:    Translation:HumansAnimalsCells
    99. Inhibition of dengue virus infections in cell cultures and in AG129 mice by a small interfering RNA targeting a highly conserved sequence. J Virol. 2011 Oct; 85(19):10154-66. Stein DA, Perry ST, Buck MD, Oehmen CS, Fischer MA, Poore E, Smith JL, Lancaster AM, Hirsch AJ, Slifka MK, Nelson JA, Shresta S, Früh K. PMID: 21795337; PMCID: PMC3196423.
      View in: PubMed   Mentions: 23     Fields:    Translation:HumansAnimalsCells
    100. Better late than never: antivirals for dengue. Expert Rev Anti Infect Ther. 2011 Jul; 9(7):755-7. Perry ST, Buck MD, Shresta S. PMID: 21810045.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCellsPHPublic Health
    101. STAT2 mediates innate immunity to Dengue virus in the absence of STAT1 via the type I interferon receptor. PLoS Pathog. 2011 Feb; 7(2):e1001297. Perry ST, Buck MD, Lada SM, Schindler C, Shresta S. PMID: 21379341; PMCID: PMC3040673.
      View in: PubMed   Mentions: 102     Fields:    Translation:AnimalsCells
    102. Important advances in the field of anti-dengue virus research. Antivir Chem Chemother. 2011; 21(3):105-16. Julander JG, Perry ST, Shresta S. PMID: 21233532.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansAnimalsCells
    103. CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination. J Immunol. 2010 Nov 01; 185(9):5405-16. Yauch LE, Prestwood TR, May MM, Morar MM, Zellweger RM, Peters B, Sette A, Shresta S. PMID: 20870934; PMCID: PMC2962919.
      View in: PubMed   Mentions: 119     Fields:    Translation:AnimalsCells
    104. Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host Microbe. 2010 Feb 18; 7(2):128-39. Zellweger RM, Prestwood TR, Shresta S. PMID: 20153282; PMCID: PMC2824513.
      View in: PubMed   Mentions: 206     Fields:    Translation:AnimalsCells
    105. Cardif-mediated signaling controls the initial innate response to dengue virus in vivo. J Virol. 2009 Aug; 83(16):8276-81. Perry ST, Prestwood TR, Lada SM, Benedict CA, Shresta S. PMID: 19494017; PMCID: PMC2715757.
      View in: PubMed   Mentions: 47     Fields:    Translation:HumansAnimalsCells
    106. A protective role for dengue virus-specific CD8+ T cells. J Immunol. 2009 Apr 15; 182(8):4865-73. Yauch LE, Zellweger RM, Kotturi MF, Qutubuddin A, Sidney J, Peters B, Prestwood TR, Sette A, Shresta S. PMID: 19342665; PMCID: PMC2674070.
      View in: PubMed   Mentions: 212     Fields:    Translation:AnimalsCells
    107. Mouse models of dengue virus infection and disease. Antiviral Res. 2008 Nov; 80(2):87-93. Yauch LE, Shresta S. PMID: 18619493; PMCID: PMC3048811.
      View in: PubMed   Mentions: 79     Fields:    Translation:HumansAnimalsCells
    108. A mouse-passaged dengue virus strain with reduced affinity for heparan sulfate causes severe disease in mice by establishing increased systemic viral loads. J Virol. 2008 Sep; 82(17):8411-21. Prestwood TR, Prigozhin DM, Sharar KL, Zellweger RM, Shresta S. PMID: 18562532; PMCID: PMC2519668.
      View in: PubMed   Mentions: 78     Fields:    Translation:AnimalsCells
    109. Murine model for dengue virus-induced lethal disease with increased vascular permeability. J Virol. 2006 Oct; 80(20):10208-17. Shresta S, Sharar KL, Prigozhin DM, Beatty PR, Harris E. PMID: 17005698; PMCID: PMC1617308.
      View in: PubMed   Mentions: 202     Fields:    Translation:AnimalsCells
    110. Critical roles for both STAT1-dependent and STAT1-independent pathways in the control of primary dengue virus infection in mice. J Immunol. 2005 Sep 15; 175(6):3946-54. Shresta S, Sharar KL, Prigozhin DM, Snider HM, Beatty PR, Harris E. PMID: 16148142.
      View in: PubMed   Mentions: 79     Fields:    Translation:AnimalsCells
    111. Interferon-dependent immunity is essential for resistance to primary dengue virus infection in mice, whereas T- and B-cell-dependent immunity are less critical. J Virol. 2004 Mar; 78(6):2701-10. Shresta S, Kyle JL, Snider HM, Basavapatna M, Beatty PR, Harris E. PMID: 14990690; PMCID: PMC353772.
      View in: PubMed   Mentions: 181     Fields:    Translation:HumansAnimalsCells
    112. Early activation of natural killer and B cells in response to primary dengue virus infection in A/J mice. Virology. 2004 Feb 20; 319(2):262-73. Shresta S, Kyle JL, Robert Beatty P, Harris E. PMID: 14980486.
      View in: PubMed   Mentions: 60     Fields:    Translation:AnimalsCells
    Sujan's Networks
    Concepts (382)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (24)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSD Profiles is managed by the UC San Diego Altman Clinical and Translational Research Institute (ACTRI).
    This site is running Profiles RNS version UCSF-v3.1.0-40-gb10dcd06 on PROFILES-PWEB04. We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use.

    Copyright © The Regents of the University of California